RZLT · TickerCove

RZLTRezolute, Inc.Healthcare · Biotechnologyas of 2026-09-16

Horizon

Issued 2026-09-16 at $3.98 · now $3.98 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, RZLT has typically landed between $2.80 and $5.82 — a range of −29.6% to +46.3% from the issuance price $3.98.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

3,410 overlapping 1 month windows · 2013-01-14 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($3.98) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$3.98 · 25% of range

$1.63 low$10.94 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

+1.0%

typical move · IQR 29.2%

−29.6%worst (p90)+46.3%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where RZLT has typically landed a month from the 2026-09-16 close of $3.98 — the range is history, not a prediction.

now $3.98 (+0.0%)
typical $4.02 (+1.0%)
middle 50% $3.44–$4.6
90% range $2.8–$5.82

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 3,410 windows spanning 2013-01-14 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2025-11-12	−83.7%	−83.7%	+9.4%
2025-11-18	−82.6%	−84.0%	+7.7%
2025-11-11	−82.1%	−82.1%	+9.0%
3 best
2020-06-30	+264.5%	+0.0%	+268.8%
2020-07-01	+244.0%	+0.0%	+244.0%
2020-06-29	+243.0%	−7.0%	+243.0%

3,410 overlapping windows · 2013-01-14 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~14 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

69%

+24.2%

n=13

Feb

36%

−4.3%

n=14

Mar

21%

−8.2%

n=14

Apr

57%

+1.5%

n=14

May

43%

−1.7%

n=14

Jun

71%

+14.3%

n=14

Jul

43%

+20.0%

n=14

Aug

43%

−0.3%

n=14

Sep

29%

−3.8%

n=14

Oct

15%

−14.6%

n=13

Nov

38%

+2.0%

n=13

Dec

23%

−10.8%

n=13

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-03-30	Evans Daron	officer	Purchase	10,000 @ $2.85	$29K	+2.5% of holding	−3.1%	not yet — horizon still open	414,462	Form 4 · filed 1 day after the trade
2025-12-16	ROBERTS BRIAN KENNETH	officer	Purchase	28,000 @ $1.70	$48K	+10.0% of holding	+33.0%	+137.6%	308,352	Form 4 · filed 1 day after the trade
2025-12-16	Hogenhuis Wladimir	director	Purchase	5,650 @ $1.69	$10K	+5.0% of holding	+33.0%	+137.6%	119,675	Form 4 · filed 1 day after the trade
2025-12-15	Evans Daron	officer	Purchase	40,000 @ $1.77	$71K	+10.6% of holding	+70.4%	+184.4%	415,900	Form 4 · filed same day
2025-12-15	Elam Nevan C	director	Purchase	32,000 @ $1.59	$51K	+5.3% of holding	+70.4%	+184.4%	641,119	Form 4 · filed same day
2025-12-15	Karnawat Sunil Ratilal	officer	Purchase	12,000 @ $1.62	$19K	+20.2% of holding	+70.4%	+184.4%	71,442	Form 4 · filed same day
2025-12-15	Evans Daron	officer	Purchase	2,500 @ $1.79	$4K	+55.6% of holding	+70.4%	+184.4%	7,000	Form 4 · filed same day
2025-12-15	Evans Daron	officer	Purchase	2,500 @ $1.78	$4K	+55.6% of holding	+70.4%	+184.4%	7,000	Form 4 · filed same day
2025-12-15	Karnawat Sunil Ratilal	officer	Purchase	100 @ $1.60	$160	+0.1% of holding	+70.4%	+184.4%	71,542	Form 4 · filed same day
2025-06-25	ROBERTS BRIAN KENNETH	officer	Purchase	2,500 @ $4.38	$11K	+19.2% of holding	+40.6%	−51.1%	15,500	Form 4 · filed 1 day after the trade
2025-06-24	Evans Daron	officer	Purchase	5,000 @ $4.05	$20K	+1.9% of holding	+33.9%	−57.0%	268,900	Form 4 · filed same day
2025-06-13	Kim Young-Jin	director	Purchase	1,230,769 @ $3.25	$4.0M	+17.1% of holding	+22.5%	−75.9%	8,423,386	Form 4 · filed 10 days after the trade
2025-06-13	KREHER NERISSA	director	Purchase	3,076 @ $3.25	$10K	+8.9% of holding	+22.5%	−75.9%	37,576	Form 4 · filed 10 days after the trade
2025-03-31	Hogenhuis Wladimir	director	Purchase	6,758 @ $2.92	$20K	+8.7% of holding	+30.5%	+204.4%	84,025	Form 4 · filed 1 day after the trade
2025-03-27	Elam Nevan C	director	Purchase	12,302 @ $2.85	$35K	+5.8% of holding	+31.6%	+202.5%	224,119	Form 4 · filed 4 days after the trade
2025-03-26	Evans Daron	officer	Purchase	10,000 @ $2.89	$29K	+4.4% of holding	+44.2%	+204.8%	237,900	Form 4 · filed 2 days after the trade
2025-03-26	Evans Daron	officer	Purchase	10,000 @ $2.88	$29K	+76.9% of holding	+44.2%	+204.8%	23,000	Form 4 · filed 2 days after the trade
2025-02-18	Hogenhuis Wladimir	director	Purchase	10,000 @ $4.70	$47K	+14.9% of holding	−22.9%	+30.4%	77,267	Form 4 · filed 2 days after the trade
2024-12-18	Evans Daron	officer	Purchase	10,000 @ $4.29	$43K	+7.1% of holding	+14.1%	−0.5%	150,900	Form 4 · filed same day
2024-12-12	Evans Daron	officer	Purchase	9,000 @ $4.60	$41K	+6.8% of holding	+1.8%	−10.5%	140,900	Form 4 · filed same day
2024-06-25	Kim Young-Jin	director	Purchase	1,250,000 @ $4.00	$5.0M	+21.0% of holding	+22.1%	+4.9%	7,192,617	Form 4 · filed 239 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

61 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-09-02	Karnawat Sunil Ratilal	officer	Withheld for tax	2,267	69,275	Form 4
2026-07-02	Elam Nevan C	director	Withheld for tax	8,004	605,497	Form 4
2026-07-02	ROBERTS BRIAN KENNETH	officer	Withheld for tax	3,062	293,851	Form 4
2026-07-02	Evans Daron	officer	Withheld for tax	3,062	411,400	Form 4
2026-03-02	Elam Nevan C	director	Withheld for tax	27,618	613,501	Form 4
2026-03-02	ROBERTS BRIAN KENNETH	officer	Withheld for tax	11,439	296,913	Form 4
2026-03-02	Evans Daron	officer	Withheld for tax	11,438	404,462	Form 4
2025-11-19	Elam Nevan C	director	Award / grant	186,000	186,000	Form 4
2025-11-19	Karnawat Sunil Ratilal	officer	Award / grant	32,000	59,442	Form 4
2025-11-19	Karnawat Sunil Ratilal	officer	Award / grant	19,000	19,000	Form 4
2025-11-19	Labrucherie Gil M	director	Award / grant	21,000	55,500	Form 4
2025-11-19	ROBERTS BRIAN KENNETH	officer	Award / grant	123,000	280,352	Form 4
2025-11-19	Hogenhuis Wladimir	director	Award / grant	21,000	114,025	Form 4
2025-11-19	Hogenhuis Wladimir	director	Award / grant	12,000	12,000	Form 4
2025-11-19	KREHER NERISSA	director	Award / grant	21,000	58,576	Form 4
2025-11-19	Labrucherie Gil M	director	Award / grant	12,000	12,000	Form 4
2025-11-19	FAUCHET PHILIPPE	director	Award / grant	21,000	55,500	Form 4
2025-11-19	FAUCHET PHILIPPE	director	Award / grant	12,000	12,000	Form 4
2025-11-19	Kim Young-Jin	director	Award / grant	21,000	170,950	Form 4
2025-11-19	Kim Young-Jin	director	Award / grant	12,000	12,000	Form 4
2025-11-19	Harris Erik	director	Award / grant	21,000	21,000	Form 4
2025-11-19	Harris Erik	director	Award / grant	12,000	12,000	Form 4
2025-11-19	KREHER NERISSA	director	Award / grant	12,000	12,000	Form 4
2025-11-19	Evans Daron	officer	Award / grant	107,000	375,900	Form 4
2025-11-19	Evans Daron	officer	Award / grant	63,000	63,000	Form 4
2025-11-19	Elam Nevan C	director	Award / grant	317,000	609,119	Form 4
2025-08-18	Karnawat Sunil Ratilal	officer	Award / grant	25,000	27,442	Form 4
2025-08-18	Karnawat Sunil Ratilal	officer	Award / grant	275,000	275,000	Form 4
2025-06-10	Elam Nevan C	director	Award / grant	68,000	292,119	Form 4
2025-06-10	Elam Nevan C	director	Award / grant	40,000	40,000	Form 4
2025-06-10	Labrucherie Gil M	director	Award / grant	9,000	34,500	Form 4
2025-06-10	Labrucherie Gil M	director	Award / grant	5,000	5,000	Form 4
2025-06-10	Evans Daron	officer	Award / grant	26,000	263,900	Form 4
2025-06-10	Evans Daron	officer	Award / grant	15,000	15,000	Form 4
2025-06-10	FAUCHET PHILIPPE	director	Award / grant	9,000	34,500	Form 4
2025-06-10	FAUCHET PHILIPPE	director	Award / grant	5,000	5,000	Form 4
2025-06-10	ROBERTS BRIAN KENNETH	officer	Award / grant	26,000	157,352	Form 4
2025-06-10	ROBERTS BRIAN KENNETH	officer	Award / grant	15,000	15,000	Form 4
2025-06-10	Kim Young-Jin	director	Award / grant	5,000	5,000	Form 4
2025-06-10	Kim Young-Jin	director	Award / grant	9,000	149,950	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-174% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i